Company Overview of EffRx Pharmaceuticals SA
EffRx, Inc. develops drug delivery solutions. It develops novel prescription and over the counter pharmaceuticals. The company offers Alendronate, a product for the treatment of osteoporosis. Its product development areas include osteoporosis, xerostomia, pain management, central nervous system, and metabolic disease/diabetes agents. The company was formerly known as Lifizz, Inc. and changed its name in 2002. EffRx, Inc. was founded in 1998 and is headquartered in Jupiter, Florida. The company has manufacturing locations in Switzerland. It has operations in Europe, Japan, and the United States.
Route de la Corniche 4
Founded in 1998
41 21 651 90 74
41 21 652 26 38
Key Executives for EffRx Pharmaceuticals SA
EffRx Pharmaceuticals SA Key Developments
Similar Private Companies By Industry
|Acino International AG||Europe|
|AL-S Pharma AG||Europe|
|Albea Pharmaceuticals AG||Europe|
|Alpen Pharma AG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact EffRx Pharmaceuticals SA, please visit www.effrx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.